ANXA4 and cancer: Not only because many studies indicated that NF-κB activation is involved in cancer drug-resistance, but also studies have indicated that other ANX family member (ANXA4) could interact with the NF-κB subunit, and ANXA2 has a similar conserved structure domain with ANXA4 [34].